Condition: Coronary Artery Disease · Sponsor: Medtronic Vascular
The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.
This description comes directly from the study's public registry record.
Jeroen Frijhoff · +31 (0)43.356.6566 · rs.prevailglobal@medtronic.com
Always discuss trial participation with your own doctor first.
| The University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Huntsville Hospital | Huntsville, Alabama, United States | Recruiting |
| Carondelet Saint Marys | Tucson, Arizona, United States | Recruiting |
| John L McClellan Memorial Veterans Hospital | Little Rock, Arkansas, United States | Recruiting |
| Stanford Hospital & Clinics | Stanford, California, United States | Recruiting |
| Medical Center of the Rockies | Loveland, Colorado, United States | Recruiting |
| Medstar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| BayCare Health System | Clearwater, Florida, United States | Recruiting |
| North Florida Regional Medical Center | Gainesville, Florida, United States | Recruiting |
| University of Miami Hospital | Miami, Florida, United States | Recruiting |
| Emory University Hospital Midtown | Atlanta, Georgia, United States | Recruiting |
| Piedmont Atlanta Hospital | Atlanta, Georgia, United States | Recruiting |
+ 39 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06535854